Literature DB >> 10687966

Surgical management of renal tumors 4 cm. or less in a contemporary cohort.

C T Lee1, J Katz, W Shi, H T Thaler, V E Reuter, P Russo.   

Abstract

PURPOSE: We evaluated a patient cohort with renal tumors 4 cm. or less treated with partial or radical nephrectomy. We compared patient and tumor characteristics, and survival in these 2 groups.
MATERIALS AND METHODS: We retrospectively analyzed the records of 670 patients with a median age of 63 years treated surgically for renal cell carcinoma between July 31, 1989 and July 31, 1997. Renal tumors 4.0 cm. or less were noted in 252 patients (38%) who underwent a total of 262 procedures, including 183 radical (70%) and 79 partial (30%) nephrectomies. Ten patients required 2 operations each because of bilateral renal cell carcinoma. Median followup was 40 months. We compared clinicopathological parameters in the partial and radical nephrectomy groups using chi-square or Wilcoxon analysis as appropriate. Survival analysis was determined by the log rank test and Cox regression model.
RESULTS: The partial and radical nephrectomy groups were comparable with respect to gender ratio, tumor presentation, histological classification, pathological stage and complication rate. Median tumor size was 2.5 and 3.0 cm. in the partial and radical nephrectomy groups, respectively (p = 0.0001). Resection was incomplete in 1 patient (1.3%) in the partial and none in the radical nephrectomy group. There was no local recurrence after either procedure, and no significant difference in disease specific, disease-free and overall survival (p = 0.98, 0.23 and 0.20, respectively).
CONCLUSIONS: Patients with a small renal tumor have similar perioperative morbidity, pathological stage and outcome regardless of treatment with partial or radical nephrectomy. Therefore, partial nephrectomy remains a safe alternative for tumors of this size.

Entities:  

Mesh:

Year:  2000        PMID: 10687966

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  116 in total

Review 1.  Should there be a size limit for elective nephron-sparing surgery?

Authors:  Kent G Krejci; Bradley C Leibovich
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

2.  Current limitations of radiofrequency ablation in renal cell carcinoma.

Authors:  Michael A S Jewett
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

Review 3.  Management of locally recurrent kidney cancer.

Authors:  Eric A Singer; Gennady Bratslavsky
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

4.  Active surveillance as the preferred management option for small renal masses.

Authors:  Ricardo A Rendon
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

5.  Maximum tensile force of different suture techniques in reconstruction of the renal remnant after nephron-sparing surgery.

Authors:  J Simon; F Finter; A Ignatius; M Meilinger; L Dürselen
Journal:  Surg Endosc       Date:  2010-07-07       Impact factor: 4.584

6.  Outcome of radiofrequency ablation over partial nephrectomy for small renal mass (<4 cm): a systematic review and meta-analysis.

Authors:  Yue Yang; Shouzhen Chen; Fan Chen; Kejia Zhu; Qiming Deng; Li Luo; Benkang Shi
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 7.  Management of small renal masses: a review.

Authors:  Mesut Remzi; Elchin Javadli; Mehmet Ozsoy
Journal:  World J Urol       Date:  2010-02-23       Impact factor: 4.226

8.  Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.

Authors:  William C Huang; Andrew S Levey; Angel M Serio; Mark Snyder; Andrew J Vickers; Ganesh V Raj; Peter T Scardino; Paul Russo
Journal:  Lancet Oncol       Date:  2006-09       Impact factor: 41.316

Review 9.  Partial nephrectomy--contemporary indications, techniques and outcomes.

Authors:  Scott Leslie; Alvin C Goh; Inderbir S Gill
Journal:  Nat Rev Urol       Date:  2013-04-16       Impact factor: 14.432

Review 10.  Oncological and renal medical importance of kidney-sparing surgery.

Authors:  Paul Russo
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.